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orrelates With Abnormal Myocardial
ontractile Reserve in Dilated Cardiomyopathy Patients
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enji Okumura, MD, PHD,* Toyoaki Murohara, MD, PHD,* Mitsuhiro Yokota, MD, PHD, FACC†
agoya, Japan
OBJECTIVES We investigated the relationship between iodine-123-metaiodobenzylguanidine (123I-
MIBG) findings and myocardial contractile reserve in patients with mild to moderate dilated
cardiomyopathy (DCM).
BACKGROUND Little is known regarding the relationship between cardiac sympathetic nervous function and
myocardial contractile reserve in DCM.
METHODS Twenty-four DCM patients who showed sinus rhythm underwent echocardiography,
biventricular catheterization, and myocardial 123I-MIBG scintigraphy. Left ventricular (LV)
pressures were measured using a micromanometer-tipped catheter. The myocardial contrac-
tile function (LV dP/dtmax) was determined at rest and during atrial pacing. The messenger
ribonucleic acid (mRNA) expressions of intracellular Ca2-regulatory proteins were analyzed
by real-time quantitative reverse transcription-polymerase chain reaction. Myocardial 123I-
MIBG accumulation was quantified as a heart-mediastinum ratio (HMR).
RESULTS A significant correlation was observed between the delayed 123I-MIBG HMR and the
percentage change in LV dP/dtmax from the baseline to the peak or critical heart rate (r 
0.64; p  0.001). The delayed 123I-MIBG HMR was significantly lower in patients showing
a worsening change in LV dP/dtmax than in those showing a favorable change (p  0.005).
The maximum LV dP/dtmax during pacing and the sarcoplasmic reticulum Ca
2-ATPase
(SERCA2) mRNA levels were significantly more reduced in patients with a delayed HMR
1.8 than in those with a delayed HMR 1.8 (p  0.05, respectively).
CONCLUSIONS Abnormal myocardial 123I-MIBG accumulation is related to an impaired myocardial
contractile reserve and down-regulation of SERCA2 mRNA in DCM. Myocardial 123I-
MIBG scintigraphy can be useful in noninvasively evaluating myocardial contractile reserve in
patients with mild to moderate DCM. (J Am Coll Cardiol 2005;46:2061–8) © 2005 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.08.046American College of Cardiology Foundation
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trevious clinical studies have demonstrated the diminished
yocardial contractile reserve in response to pacing-induced
achycardia in patients with dilated cardiomyopathy (DCM)
1,2). Some studies have shown that myocardial contractile
eserve reflects the severity of DCM and is a prognostic
eterminant in patients with idiopathic DCM (3,4). In
eneral, myocardial contractile function is thought to be
etermined by myocardial intracellular Ca2 handling,
hich consists of Ca2 releasing factors from sarcoplasmic
eticulum such as ryanodine receptor-2 and intracellular
a2-regulating factors such as sarcoplasmic reticulum
a2-ATPase (SERCA2) and phospholamban (5–8). We
reviously demonstrated the relationship between an abnor-
al myocardial contractile reserve and a reduced messenger
ibonucleic acid (mRNA) expression of SERCA2 in pa-
ients with hypertrophic cardiomyopathy (9). Therefore, it
From the Departments of *Cardiology and †Cardiovascular Genome Science,
agoya University School of Medicine, Nagoya, Japan; ‡Department of Medical
echnology, Nagoya University School of Health Science, Nagoya, Japan; and the
Department of Radiology, Nagoya University Hospital, Nagoya, Japan.i
Manuscript received January 21, 2005; revised manuscript received June 30, 2005,
ccepted August 1, 2005.s of interest to assess the relation of myocardial contractile
eserve to Ca2-handling proteins in DCM.
Iodine-123-metaiodobenzylguanidine (123I-MIBG) is a
seful imaging tracer that shares similar myocardial uptake,
torage, and release mechanisms as norepinephrine (NE) in
ympathetic nerve terminals. Measurements of a 123I-
IBG heart-mediastinum ratio (HMR) and washout rate
ave enabled more detailed assessment of the function and
ntegrity of myocardial sympathetic innervation. It is well
nown that myocardial 123I-MIBG accumulation is reduced
n patients with heart failure by enhanced NE spillover from
ardiomyocyte (10). It has been reported that reduced
yocardial 123I-MIBG accumulation is correlated with
iminished left ventricular (LV) function in patients with
eart failure (11,12). However, the relation between cardiac
ympathetic function and myocardial contractile reserve in
atients with DCM still remains to be established.
Accordingly, in the present study we determined the
elationship between cardiac sympathetic function, contrac-
ile reserve, and myocardial cellular Ca2 handling, and
nvestigated whether myocardial 123I-MIBG scintigraphy
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MIBG and Contractile Reserve in DCM December 6, 2005:2061–8ould be useful in noninvasively evaluating myocardial
ontractile reserve in patients with mild to moderate DCM.
ATERIALS AND METHODS
tudy population. Twenty-four patients with mild to
oderate DCM, who showed sinus rhythm on electrocar-
iogram, were enrolled in this study. A detailed history was
btained and a physical examination was performed for all
atients before inclusion in this study. According to the
efinition of the World Health Organization/International
ociety and Federation of Cardiology, DCM is a heart
uscle disease of unknown origin with predominant im-
airment of the systolic function (13). Criteria for enroll-
ent in this study were normal coronary artery and no
vidence of specific cardiomyopathy such as ischemic, val-
ular, hypertensive, diabetic, alcoholic, inflammatory, or
ystemic cardiomyopathy. Patients were excluded if they
ad atrial fibrillation, neuromuscular diseases, or parkinson-
sm. No patients had received reserpine, tricyclic antidepres-
ant, or other drugs that could interfere with NE kinetics.
ll patients were hospitalized for examinations and under-
ent echocardiography, cardiac catheterization, and resting
yocardial 123I-MIBG scintigraphy. Endomyocardial bi-
psy was performed to analyze real-time quantitative reverse
ranscription-polymerase chain reaction (RT-PCR). Six-
een patients had been treated with angiotensin-converting
nzyme inhibitors, thirteen with diuretics, eight with digi-
alis, six with angiotensin receptor blockades, and three with
eta-blockers. All medications were withdrawn at least 72 h
efore the study. The study protocol was approved by our
nstitutional review committee. Written informed consent
as obtained from all patients.
23I-MIBG imaging. Myocardial 123I-MIBG scintigraphy
as performed after an overnight fast. One hundred forty-
ight MBq (4 mCi) of 123I-MIBG was injected intrave-
ously through the antecubital vein at rest. The planar view
as obtained approximately 15 min and 4 h after the tracer
njection. A two-head gamma camera (ECAM; Toshiba,
okyo, Japan) equipped with a low-energy high-resolution
ollimator was rotated over a 180° arc with an acquisition
Abbreviations and Acronyms
DCM  dilated cardiomyopathy
HMR  heart-mediastinum ratio
123I-MIBG  iodine-123-metaiodobenzylguanidine
LV  left ventricular
LV dP/dtmax  maximum first derivative of left
ventricular pressure
LVEF  left ventricular ejection fraction
mRNA  messenger ribonucleic acid
NE  norepinephrine
SERCA2  sarcoplasmic reticulum Ca2-ATPase
T1/2  pressure half-timeime of 20 s per image at 4° intervals for each view. Energy biscrimination was provided by a 20% window centered at
59 keV.
iventricular cardiac catheterization and echocardio-
raphy. All patients underwent biventricular catheteriza-
ion using brachial approach in fasting state. A 20-gauge
atheter was placed in the left brachial artery to measure
rterial pressures. A 6-F fluid-filled pigtail catheter with a
igh-fidelity micromanometer (model SPC-464D; Millar
nstruments, Houston, Texas) was advanced into the LV
avity through a 6-F sheath in the right brachial artery to
easure LV pressures. A 7-F triple-lumen Swan-Ganz
hermodilution catheter (Baxter Healthcare, Deerfield, Illi-
ois) was positioned in the right pulmonary artery through
he right brachial vein to measure pulmonary artery wedge
ressure (PAWP) and cardiac index (CI). A 6-F bipolar
acing catheter was introduced through the right subclavian
ein and positioned in the high right atrium. After baseline
ata were obtained, right atrial pacing was initiated at 80
eats/min and increased in increments of 10 beats/min up to
he maximum value of 140 beats/min.
All patients underwent two-dimensional echocardiogra-
hy with a Hewlett-Packard ultrasound system (Sonos
500; Andover, Massachusetts) equipped with a 2.5- to
.5-MHz transducer to measure wall thickness, cardiac
hamber size, and fractional shortening (FS) at rest.
23I-MIBG analysis. Myocardial 123I-MIBG uptake was
uantified in anterior planar views at 15 min (early image)
nd 4 h (delayed image) after tracer injection. After regions
f interest over the whole heart (H) and over the upper
ediastinum (M) were set, an HMR was calculated. In our
aboratory, the normal 123I-MIBG HMR values of the early
nd delayed images obtained from other age-matched con-
rols (9 male and 1 female, mean age 53  9 years) were 1.9
o 2.8 and 1.8 to 2.7, respectively.
ardiac hemodynamic analysis. Micromanometer pres-
ure signals and standard electrocardiograms were recorded
ith a multichannel recorder (MR-40, TEAC, Tokyo,
apan) throughout the study. Left ventricular pressure sig-
als were digitized at 3-ms intervals and analyzed with
oftware developed in our laboratory with a 32-bit micro-
omputer system (PC-9821-ST20; NEC, Tokyo, Japan).
emodynamic data were analyzed by two independent
bservers who were unaware of the clinical, echocardio-
raphic, and scintigraphic data. We selected steady-state
V pressure data at baseline and at each pacing rate for
nalysis, then measured LV end-diastolic pressure
LVEDP), the maximum first derivative of LV pressure
LV dP/dtmax) as an index of contractility, and the pressure
alf-time (T1/2) to evaluate LV isovolumic relaxation ac-
ording to Mirsky’s method (14). A biphasic pattern of
hange, with an initially positive and subsequently negative
lope in the force-frequency relation, and a flat pattern of
hange without initial increasing in the force-frequency
elation (e.g., the percent change in LV dP/dtmax from the
aseline to the maximum value is 10%) are considered to
e worsening changes. Both patterns of changes indicate
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December 6, 2005:2061–8 MIBG and Contractile Reserve in DCMmpairment in myocardial contractile reserve (15). We
efined the critical heart rate (HR) as the HR at which LV
P/dtmax reached the maximum value during a progressive
ncrease in HR. Thus, the value beyond which LV dP/dtmax
eclined by 5% was the critical HR for isovolumic contrac-
ion (16,17). The peak pacing rates were defined as the HR
t which either second-degree atrioventricular block or
ulsus alternans occurred (17).
After completion of the pacing study, selective coronary
ngiography, left ventriculography, and endomyocardial bi-
psy were performed. Left ventricular end-diastolic volume,
V end-systolic volume, and stroke volume were measured
y contrast-enhanced left ventriculography. Left ventricular
nd-diastolic volume index (LVEDVI), LV end-systolic
olume index (LVESVI), stroke volume index (SI), and LV
jection fraction (LVEF) were calculated according to the
andler and Dodge method (18). In right cardiac catheter-
zation, PAWP and CI were measured using a Swan-Ganz
hermodilution catheter. Several biopsy specimens were
btained from the left side of the interventricular septum.
iopsy specimens for mRNA analysis were frozen immedi-
tely in liquid nitrogen and stored at 80°C until use.
Echocardiographic data were analyzed by two indepen-
ent observers who were unaware of the clinical, hemody-
amic, and scintigraphic data. In two-dimensional echocar-
iography, the LV end-diastolic dimension (LVEDD), LV
nd-systolic dimension (LVESD), interventricular septal
hickness (IVST), posterior wall thickness (PWT), and FS
ere measured on the M-mode of the long-axis image
ccording to standard criteria (19).
easurement of neurohumoral factors. The blood sam-
le was immediately placed on ice and centrifuged at 4°C.
he plasma NE levels were measured using high-
erformance liquid chromatography. The plasma brain
atriuretic peptide (BNP) levels were measured with a
pecific radioimmunoassay for human BNP using a com-
ercially available kit.
T-PCR analysis. The total ribonucleic acid was isolated
rom 1 to 2.5 mg of the frozen samples of LV biopsy
pecimens and subjected to real-time quantitative RT-PCR
nalysis as previously described (20). The mRNA expres-
ions of intracellular Ca2-regulatory proteins, including
ERCA2, ryanodine receptor-2, phospholamban, calse-
uestrin, and Na/Ca2 exchanger, were analyzed by a
uorogenic 5=-nuclease PCR assay using an ABI PRISM
700 sequence detector (Perkin-Elmer, Wellesley, Massa-
husetts). All PCR assays were performed in triplicate.
aqMan glyceraldehyde-3-phosphate dehydrogenase
GAPDH) control reagents (Perkin-Elmer) were used for
he detection of human GAPDH transcript as an internal
tandard.
tatistical analysis. Data were expressed as mean values 
D. An unpaired Student t test was performed to determine
ifferences between mean values for continuous variables
hen appropriate. Neurohumoral factors (BNP, NE) were
ot normally distributed. Therefore, the nonparametric wann-Whitney U test was used to assess differences.
orrelations between scintigraphic and hemodynamic pa-
ameters were performed by linear regression analysis. A
ultiple linear regression analysis was performed using the
ercentage change in LV dP/dtmax as dependent parameter.
ge, LV wall thickness, LV volume index, LVEF, neuro-
umoral factors, and delayed 123I-MIBG HMR were used
s independent parameters. The partial regression coeffi-
ient () was calculated to assess significant independent
arameters. A threshold value of a delayed MIBG HMR for
etecting an abnormal contractile response was defined by
eceiver-operating characteristic analysis. A p value 0.05
as considered statistically significant.
ESULTS
atient demographics. The demographics of the patients
nrolled in this study are summarized in Table 1. The mean
ge of the 24 patients (20 men, 4 women) was 53  10
ears. Nineteen patients were classified as New York Heart
ssociation (NYHA) functional class I, and five patients as
YHA class II. The mean cardiothoracic ratio was 52 
%. The LVEDD and LVESD derived from echocardiog-
aphy were 59  10 mm and 47  9 mm, respectively, and
he LVEDVI and LVESVI derived from contrast ventricu-
ography were 90  55 ml/m2 and 55  25 ml/m2,
espectively, suggesting LV dilatation. The IVST and PWT
ere 8.3  1.3 mm and 8.3  1.3 mm, respectively,
uggesting a tendency to wall thinning. The LVEF and FS
able 1. Patient Demographics
ender (M/F) 20/4
ge (yrs) 53  10
YHA functional class (n)
I 19
II 5
TR (%) 52  7
chocardiography
IVST (mm) 8.3  1.3
PWT (mm) 8.3  1.3
LVEDD (mm) 59  10
LVESD (mm) 47  9
LAD (mm) 42  8
FS (%) 21  5.0
ardiac catheterization
LVEDVI (ml/m2) 90  55
LVESVI (ml/m2) 55  25
SI (ml/m2) 35  10
LVEF (%) 41  7.0
LVEDP (mm Hg) 17  8.9
PAWP (mm Hg) 12  7.2
CI (l/mim/m2) 3.6  1.1
ata are expressed as mean values  SD.
CI  cardiac index; CTR  cardiothoracic ratio; FS  fractional shortening;
VST  interventricular septal thickness; LAD  left atrial dimension; LVEDD 
eft ventricular end-diastolic dimension; LVEDP  left ventricular end-diastolic
ressure; LVEDVI  left ventricular end-diastolic volume index; LVEF  left
entricular ejection fraction; LVESD  left ventricular end-systolic dimension;
VESVI  left ventricular end-systolic volume index; NYHA  New York Heart
ssociation; PAWP  pulmonary artery wedge pressure; PWT  posterior wall
hickness; SI  stroke index.ere reduced, with mean values of 41  7.0% and 21 
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MIBG and Contractile Reserve in DCM December 6, 2005:2061–8.0%, respectively. The mean values of early HMR and
elayed HMR were 1.97  0.34 and 1.83  0.30, respec-
ively. Eleven patients showed a debilitating pattern of
hanges in LV dP/dtmax, and 13 showed a favorable pattern.
elationship between 123I-MIBG findings and hemody-
amic parameters. No adverse complications were ob-
erved in the hemodynamic study. A significant correlation
as observed between the delayed 123I-MIBG HMR and
he percentage change in LV dP/dtmaxfrom the baseline to
he peak or critical HR (r  0.64; p  0.001) (Fig. 1). A
ositive linear correlation was observed between the delayed
23I-MIBG HMR and the percentage shortening in T1/2
rom the baseline to the peak HR, but it did not reach
tatistical significance (r  0.35; p  0.08). No significant
orrelation was observed between the delayed HMR and
ther hemodynamic parameters (LV dimensions, LVEF,
V volume indexes, LVEDP, PAWP, or CI) derived from
chocardiography or biventricular catheterization. No sig-
ificant correlation was observed between the early 123I-
IBG HMR and any hemodynamic parameters. A multi-
le regression analysis revealed that the delayed 123I-MIBG
MR was a significant independent parameter for the
ercentage change in LV dP/dtmax (  0.47; p  0.03).
omparison of patients with and without worsening
hanges in LV dP/dtmax. When we divided the DCM
atients based on the rate-dependent changes in LV dP/
tmax, the delayed
123I-MIBG HMR was significantly lower
n patients with worsening changes than in those showing
on-worsening changes (p  0.005) (Table 2). In the
chocardiographic study, the LVEDD and LVESD were
ignificantly greater in patients showing worsening changes
han in those showing non-worsening changes in LV
P/dtmax (p  0.05) (Table 2). In the hemodynamic study,
o significant difference was observed in the percentage
hange in HR during the pacing study in the two groups.
o significant difference was observed in the baseline
ystolic blood pressure, the baseline diastolic blood pressure,
he peak systolic blood pressure, or the peak diastolic blood
igure 1. Relationship between the delayed iodine-123-metaiodobenzyl-
uanidine heart-mediastinum ratio (HMR) and the percentage change ina
V dP/dtmax from the baseline to the peak or critical heart rate. LV
P/dtmax  maximum first derivative of left ventricular pressure.ressure in the two groups (Table 2). The LVEDVI and
VESVI were also significantly greater in patients showing
orsening changes than in those showing non-worsening
hanges (p  0.05, respectively) (Table 2). The peak T1/2
as significantly less prolonged in patients with worsening
hanges than in those showing non-worsening changes (p
.05) (Table 2). The calsequestrin mRNA levels were
ignificantly lower in patients with worsening changes than
n those showing non-worsening changes (p 0.05) (Table 2).
omparison of patients with and without a low HMR. At
he threshold value of a delayed 123I-MIBG HMR of 1.8,
he sensitivity, specificity, and accuracy for detecting pa-
ients showing worsening changes in LV dP/dtmaxwere
1.8%, 84.6%, and 83.3%, respectively, using receiver-
perating characteristic analysis. According to the quanti-
ative 123I-MIBG findings, we divided the DCM patients
nto two groups as follows: 10 patients with a low delayed
MR (delayed HMR 1.8) and 14 without it (delayed
MR 1.8).
The maximum LV dP/dtmax during pacing was signifi-
antly more reduced in patients with a low HMR than in
hose without it (1,337  275 mm Hg/s vs. 1,705  349
m Hg/s; p  0.011). The percentage change in LV
P/dtmax from the baseline to the peak or critical HR was
ess in patients with a low HMR than in those without it (11
5.4% vs. 20 8.3%; p 0.0079). The worsening change
n LV dP/dtmax was more frequently observed in patients
ith a low HMR than in those without it (8 of 10 patients
80%] vs. 2 of 14 patients [14%]; p  0.0008). The
ercentage shortening in T1/2 from the baseline to the peak
R was significantly less in patients with a low HMR than
n those without it (21  7.2% vs. 30  5.8%; p 
.047). The plasma NE levels were higher in patients with
low HMR than in those without it (671  266 pg/ml vs.
60  173 pg/ml; p  0.0091). The SERCA2 mRNA
evels were significantly lower in patients with a low HMR
han in those without it (SERCA2/GAPDH ratio: 0.335
.053 vs. 0.453  0.053; p  0.01).
Myocardial 123I-MIBG scintigraphy and the changes in
V dP/dtmax of two typical cases are presented in Figures 2
nd 3.
ISCUSSION
n this study, a significant correlation was observed between
he change in the acceleration of contractility (percentage
hange in LV dP/dtmax from the baseline to the peak or
ritical HR) during atrial pacing and the quantitative
yocardial 123I-MIBG uptake (delayed 123I-MIBG
MR). Patients with an inability to increase LV dP/dtmax
xhibited lower 123I-MIBG HMR than those without it. In
ddition, the SERCA2 mRNA levels were lower in patients
ith impaired sympathetic nervous function than in those
ith relatively preserved function. These results suggest thatbnormal 123I-MIBG findings may be related to the im-
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December 6, 2005:2061–8 MIBG and Contractile Reserve in DCMaired myocardial contractile reserve in response to atrial
acing in patients with mild to moderate DCM.
bnormal myocardial contractile reserve in DCM. In
his study, impaired cardiac sympathetic function was re-
ated to an impaired force-frequency relation during atrial
Table 2. Comparison of Patients Showing Non
Changes in LV dP/dtmax
Parameters
Non-Wo
(n
Gender (M/F)
Age (yrs) 5
NYHA functional class (n)
I
II
CTR (%) 5
Echocardiography
IVST (mm) 8
PWT (mm) 8
LVEDD (mm) 5
LVESD (mm) 4
LAD (mm) 4
FS (%) 2
Cardiac catheterization
Baseline HR (beats/min) 7
Peak HR (beats/min) 13
Baseline SBP (mm Hg) 14
Peak SBP (mm Hg) 14
Baseline DBP (mm Hg) 8
Peak DBP (mm Hg) 8
LVEDVI (ml/m2) 14
LVESVI (ml/m2) 8
SI (ml/m2) 6
LVEF (%) 4
Baseline LVEDP (mm Hg) 1
Peak LVEDP (mm Hg)
LVEDP (mm Hg) 
Baseline LV dP/dtmax (mm Hg/s) 143
Peak LV dP/dtmax (mm Hg/s) 170
%LV dP/dtmax (%) 1
Baseline T1/2 (ms) 4
Peak T1/2 (ms) 3
%T1/2 (%) 2
PAWP (mm Hg) 1
CI (l/min/m2) 4
Neurohumoral factors
NE (pg/ml) 43
BNP (pg/ml) 11
mRNA expression of intracellular
Ca2-regulatory proteins
SERCA2/GAPDH 0.3
RyR/GAPDH 1.2
PLB/GAPDH 0.3
CQ/GAPDH 1.5
Na/Ca2 exchanger/GAPDH 2.1
MIBG scintigraphy
Early HMR 2
Delayed HMR 1
Data are expressed as mean values  SD.
BNP  brain natriuretic peptide; CQ  calsequestrin;
phosphate dehydrogenase; HR  heart rate; HMR  heart
left ventricular pressure; NE  norepinephrine; PAWP  p
ryanodine receptor-2; SBP  systolic blood pressure; SER
half-time; %  percentage change in parameters from the b
parameters from the baseline to the peak or critical heart ratacing. In general, myocardial contractile function is af- (ected by intramyocardial Ca2 concentration, which is
egulated by Ca2-handling and Ca2-releasing factors
5–8). We previously demonstrated that an abnormal con-
ractile reserve is caused by a reduced mRNA expression of
ERCA2 in patients with hypertrophic cardiomyopathy
rsening With Those Showing Worsening
g Pattern
3)
Worsening Pattern
(n  11) p Value
10/1
9 52  11 0.74
8
3
3 52  4 0.80
1.3 8.0  1.3 0.60
1.4 8.1  1.3 0.43
5 64  12 0.013
3 52  10 0.0054
8 45  8 0.18
6.7 19  3.3 0.21
16 73  15 0.71
9 132  10 0.17
27 128  20 0.12
22 147  24 0.70
18 77  11 0.29
10 86  14 0.37
27 220  96 0.015
15 144  76 0.0089
20 76  35 0.25
5 39  6 0.21
7 18  11 0.89
7 5  6 0.34
6 13  9 0.24
237 1425  257 0.95
336 1661  343 0.78
15 16  11 0.57
8.3 38  6.5 0.22
8.0 28  5.4 0.047
7.4 33  14.3 0.13
5.2 13  9.3 0.57
1.3 3.2  0.7 0.11
179 648  349 0.13
178 94  148 0.76
0.51 0.40  0.12 0.98
0.51 0.90  0.29 0.30
0.13 0.53  0.37 0.29
0.55 0.67  0.033 0.037
0.82 1.82  0.78 0.52
0.3 1.8  0.3 0.054
0.2 1.6  0.3 0.0038
 diastolic blood pressure; GAPDH  glyceraldehyde-3-
iastinum ratio; LV dP/dtmax  maximum first derivative of
ary artery wedge pressure; PLB  phospholamban; RyR 
 sarcoplasmic reticulum Ca2-ATPase; T1/2  pressure
e to the peak or critical heart rate;   absolute change in
er abbreviations as in Table 1.-Wo
rsenin
 1
10/3
4 
11
2
2 
.5 
.5 
5 
2 
2 
2 
7 
7 
4 
3 
4 
1 
7 
2 
3 
2 
7 
8 
9 
1 
1 
9 
2 
4 
2 
1 
.0 
9 
7 
9 
8 
6 
1 
7 
.0 
.9 
DBP
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MIBG and Contractile Reserve in DCM December 6, 2005:2061–8howed reduced mRNA expression of calsequestrin, and no
ignificant difference in mRNA abundance for SERCA2
as observed between the subgroups. However, SERCA2/
APDH ratio was significantly lower in DCM patients
ith a low HMR than in those without it, probably
ndicating that reduced expression of SERCA2 is associated
ith impaired cardiac sympathetic activity. Previous studies
ave mentioned that expression of SERCA2 increases after
eta-blocker treatment, suggesting a causal link between
eta-blocker therapy and expression of Ca2-regulatory
roteins in patients with mild to moderate heart failure
21,22). Our results may support the demonstrations of
igure 2. A representative case of a 50-year-old woman. Left ventricular eje
NYHA) functional class II. (A) Increased lung uptake and severely reduce
elayed HMR is 1.4. (B) The relationship between heart rate (HR) and L
V dP/dtmax are 1,107 mm Hg/s and 1,284 mm Hg/s, respectively. The p
biphasic pattern of change in LV dP/dtmax is observed. bpm  beats p
igure 3. A case of a 60-year-old man. LVEF is 45%, and this patient is in N
nferior wall on the delayed 123I-MIBG planar image. The delayed HMR is 2.
aseline LV dP/dtmax and maximum LV dP/dtmax are 1,224 mm Hg/s and 1,509 mm
o the peak HR is 27%. A progressively increasing pattern of change in LV dP/dtmhese previous studies. Abnormal quantitative 123I-MIBG
ndings may reflect the abnormal myocardial contractile
eserve, which is associated with abnormal Ca2 handlings.
We found that some DCM patients show worsening
hanges in LV dP/dtmax. Previous clinical studies have
emonstrated diminished myocardial contractile reserve
uring pacing-induced tachycardia in patients with DCM
1,2). Some studies have also indicated that potentiation of
he force of contraction is attenuated or absent in the failing
yocardium (15,23,24). These results are in accord with our
esults. In DCM patients with worsening changes in LV
P/dtmax, the delayed
123I-MIBG HMR was significantly
fraction (LVEF) is 35%, and this patient is in New York Heart Association
cardial uptake are observed on the delayed 123I-MIBG planar image. The
/dtmax of this patient is shown. The baseline LV dP/dtmax and maximum
tage change in LV dP/dtmax from the baseline to the critical HR is 10%.
nute; other abbreviations as in Figure 1.
functional class I. (A) Mildly reduced myocardial uptake is observed in the
The relationship between HR and LV dP/dtmax of this patient is shown. Thection
d myo
V dPYHA
0. (B)Hg/s, respectively. The percentage change in LV dP/dtmax from the baseline
ax is observed. Abbreviations as in Figures 1 and 2.
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December 6, 2005:2061–8 MIBG and Contractile Reserve in DCMower compared with those showing non-worsening
hanges. The plasma NE levels were higher in patients with
low HMR than in those without it. In the failing myocar-
ium, a reduced intramyocardial NE content and down-
egulation of beta-receptors have been reported (25–27).
oreover, another study demonstrated that reduced con-
ractile reserve in the papillary muscle is yielded by the
epletion of intramyocardial NE contents in the failing
uman heart (28). Accordingly, we assume that the abnor-
al myocardial contractile reserve may be at least in part
aused by the depletion of intramyocardial NE contents.
ctually, we could not address the mechanism by which
ardiac sympathetic nervous dysfunction is involved in a
educed contractile reserve in response to atrial pacing
timulation. However, our result, which demonstrated a
ignificant correlation between cardiac sympathetic function
nd myocardial contractile function, may suggest that car-
iac adrenergic nervous integrity, at least in part, plays a role
n regulating myocardial contractile function.
uantitative 123I-MIBG parameters. A previous study
eported that an increase in NE turnover at cardiac sympa-
hetic nerve endings led to a decrease in uptake in the delayed
mage, so that the increase in turnover, that is, an increase in
ashout rate, depended on the severity of the impaired
ympathetic function (29). Moreover, another study reported
hat because the neuronal accumulation of 131I-MIBG reaches
peak value 4 h after tracer administration, the neuronal
ptake of NE can be evaluated accurately if the 131I-MIBG
maging is performed 4 h after tracer administration (30).
urthermore, it is reported that the early 125I-MIBG uptake
eflects only the integrity of presynaptic nerve terminals and
ptake-1 function, whereas the delayed 125I-MIBG uptake
ncludes overall information regarding neuronal function from
ptake to release through the storage system at nerve terminals
31). The delayed image can reflect the severity of heart
iseases more accurately than the early image. Given these
dvantages of using the delayed HMR, we used it to classify
he DCM patients in this study. A significant correlation was
bserved between the delayed 123I-MIBG HMR and myocar-
ial contractile reserve. In contrast, no significant correlations
ere observed between the early HMR and myocardial con-
ractile reserve. Our results may be supported by the rationale
iven in two previous studies (30,31).
linical implications. In this study, the delayed 123I-MIBG
MR correlated with myocardial contractile reserve (percent-
ge change in LV dP/dtmax). In addition, the maximum LV
P/dtmax was more reduced, and the percentage change in LV
P/dtmax and T1/2 (relaxation-frequency relation) was less in
CM patients with severely impaired sympathetic nervous
unction than in those with mild impairment. However, no
ignificant correlation was observed between the 123I-MIBG
MR and other functional parameters derived from echocar-
iography or cardiac catheterization. In general, it is well
nown that LVEF and LV volumes are associated with the
linical outcome or prognosis of patients with heart failure.
owever, they are more operator-dependent factors and tend co be more affected by pre- and afterload than myocardial
roperties derived from catheterization. On the other hand, it
as been reported that increased cardiac NE spillover in
ongestive heart failure, which reflects an increased sympa-
hetic nervous activity, is associated with both malignant
entricular arrhythmias and poor prognosis (32,33). Our re-
ults, in which plasma NE levels were significantly higher in
CM patients with severely reduced MIBG uptake than in
hose with mildly reduced MIBG uptake, may indicate that
CM patients with reduced 123I-MIBG uptake show in-
reased NE spillover. It is well known that the prognosis of
CM patients with severely impaired LV function is very
oor. Conversely, it is important to assess which factors are
redictive for clinical outcome in DCM patients with mildly to
oderately impaired LV function. Myocardial contractile re-
erve is reported to be an important prognostic determinant in
atients with idiopathic DCM without overt heart failure (3).
ccordingly, from the viewpoint of our results, the delayed
23I-MIBG HMR may be better than other functional param-
ters to indicate mild to moderate DCM patients with an
mpaired contractile reserve who will show a poor clinical
utcome. Myocardial 123I-MIBG scintigraphy may be useful
ot only in noninvasively evaluating the degree of impaired
yocardial reserve but in reflecting clinical outcome in mild to
oderate DCM patients. However, further studies will be
eeded to elucidate the relationship among the cardiac sym-
athetic function, myocardial function, and prognosis in a
arger patient population.
It has been reported that beta-blockers provide long-term
enefits in patients with severe heart failure (34,35). To
larify the impacts of a beta-blocker on delayed 123I-MIBG
ccumulation and decreased contractile reserve, further in-
estigations must be made.
tudy limitations. Clinically stable and ambulatory pa-
ients with sinus rhythm were enrolled in this study.
oreover, our patients were in NYHA functional classes I
nd II, indicating DCM patients at relatively early stages.
herefore, our results may not be widely extrapolated to
atients with more severe LV dysfunction. However, in this
tudy we aimed to clarify the correlation between sympa-
hetic nervous activity and myocardial function in DCM
atients at the early stage.
It would have been preferable to measure the protein
bundance of these proteins and/or their degree of phos-
horylation to gain insight into the basis for the differences
n physiologic responses between the subgroups of patients
efined by differences in their 123I-MIBG HMR. However,
t is difficult to analyze protein abundance and its function in
he small amount of tissues generated by percutaneous LV
iopsies. Accordingly, we assessed the Ca2-handling pro-
eins by RT-PCR only.
We defined the delayed 123I-MIBG cutoff value of 1.8 on
he basis of receiver-operating characteristic analysis. We
elieve that this value is useful in predicting DCM patients
howing an abnormal contractile reserve. However, this
utoff value may not be extrapolated as predictive of the
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MIBG and Contractile Reserve in DCM December 6, 2005:2061–8ifferences observed in a different study population, and the
alidation of this value would be needed in future studies.
ONCLUSIONS
yocardial 123I-MIBG accumulation is related to myocar-
ial contractile reserve in patients with DCM. In addition,
educed myocardial 123I-MIBG accumulation may be re-
ated to the down-regulation of SERCA2 mRNA expres-
ion, which indicates an altered Ca2 handling. The myo-
ardial 123I-MIBG scintigraphy may reflect myocardial
ontractile reserve, and may be useful in noninvasively
etecting DCM patients with moderately impaired LV
unction who will progress to an advanced stage. However,
urther studies including prognostic evaluation will be
eeded to clarify this issue in a larger population.
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